ArticleFrontiers in oncology2022

Cost-effectiveness of precision screening for esophageal cancer based on individualized risk stratification in China: Real-world evidence from the ESECC trial.

Fuxiao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.